help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Torney, A. H.
Right arrow Articles by de Kretser, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Torney, A. H.
Right arrow Articles by de Kretser, D. M.

Endocrinology, Vol 127, 2938-2946, Copyright © 1990 by Endocrine Society


ARTICLES

In vitro bioactive and immunoactive inhibin concentrations in bovine fetal ovaries and testes throughout gestation

AH Torney, DM Robertson, YM Hodgson and DM de Kretser
Department of Anatomy, Monash University, Clayton, Victoria, Australia.

This study investigates the concentrations of inhibin in the bovine fetal ovary and testis throughout gestation (days 40 to 270/term) as determined by inhibin in vitro bioassay and RIA techniques. In addition, the expression of the inhibin alpha- and beta-subunits (beta A and beta B) in these tissues was evaluated by Northern blot analysis and in situ hybridization. Testicular concentrations of inhibin bioactivity and immunoactivity increased 2.5-fold (103 +/- 24.5 to 256 +/- 11.7 U/g wet weight; mean +/- SE) and 10.4-fold (139 +/- 56 to 1430 +/- 172) respectively, between 90 days and term. The corresponding ratio of inhibin biological: immunological activities (B/I ratio) decreased 8.3-fold (1.5 +/- 0.7 to 0.18 +/- 0.01). The concentration of ovarian bioactive inhibin increased significantly (P less than 0.05) 4.6-fold between 90 days and term (73.6 +/- 14.7 to 340 +/- 11.1 U/g wet weight), whereas the immunoactive inhibin concentration increased 10.3-fold between 120 and 210 days of gestation (7.2 +/- 1.9 to 40.0 +/- 8.7). The corresponding B/I ratio remained unchanged throughout gestation (8.3 +/- 2.4 to 12.5 +/- 4.0). Although the levels of alpha subunit mRNA in the testis and ovary increased over gestation, the levels of testicular beta A subunit mRNA remained low and unchanged. Ovarian levels of beta A subunit mRNA were also low but variable. Furthermore, no beta B subunit mRNA could be detected in gonadal tissue throughout gestation. alpha-Subunit mRNA was detected by in situ hybridization in the sex cords of the fetal testis and the granulosa cells of the fetal ovary while beta A subunit mRNA was detected only in the granulosa cells of the fetal ovary. It is concluded that inhibin is produced by the fetal testis and ovary and these tissue levels increase throughout gestation. The location of alpha- and beta A-subunit mRNA to the sex cords of the testis and granulosa cells of the ovary indicate that these cells are the primary source of inhibin production. The rapid fall in inhibin B/I ratio in testicular extracts over gestation is attributed to the production of an inhibin-related protein with limited or negligible biological activity.


This article has been cited by other articles:


Home page
Biol. Reprod.Home page
H. Kaneko, J. Noguchi, K. Kikuchi, and Y. Hasegawa
Molecular Weight Forms of Inhibin A and Inhibin B in the Bovine Testis Change with Age
Biol Reprod, May 1, 2003; 68(5): 1918 - 1925.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
Y. Tanaka, H. Taniyama, N. Tsunoda, C. B. Herath, R. Nakai, H. Shinbo, N. Nagamine, Y. Nambo, S.-i. Nagata, G. Watanabe, et al.
Localization and Secretion of Inhibins in the Equine Fetal Ovaries
Biol Reprod, January 1, 2003; 68(1): 328 - 335.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. O. Bahathiq, R. L. Stewart, M. Wells, H. D. Moore, A. A. Pacey, and W. L. Ledger
Production of Activins by the Human Endosalpinx
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5283 - 5289.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
H. Kaneko, J. Noguchi, K. Kikuchi, S. Akagi, A. Shimada, K. Taya, G. Watanabe, and Y. Hasegawa
Production and Endocrine Role of Inhibin During the Early Development of Bull Calves
Biol Reprod, July 1, 2001; 65(1): 209 - 215.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. A. Jarred, B. Cancilla, M. Richards, N. P. Groome, K. P. McNatty, and G. P. Risbridger
Differential Localization of Inhibin Subunit Proteins in the Ovine Testis during Fetal Gonadal Development
Endocrinology, February 1, 1999; 140(2): 979 - 986.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
L. Gnessi, A. Fabbri, and G. Spera
Gonadal Peptides as Mediators of Development and Functional Control of the Testis: An Integrated System with Hormones and Local Environment
Endocr. Rev., August 1, 1997; 18(4): 541 - 609.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society